Buccal Drug Delivery: Past, Present and Future – A Review
Keywords:
complexation, parenteral, transdermal, trasmucosalAbstract
The major hindrance for the absorption of a drug taken orally is extensive first pass metabolism or stability problems within the GI environment like instability in gastric pH and complexation with mucosal membrane. These obstacles can be overcome by altering the route of administration as parenteral, transdermal or trasmucosal. Among these trasmucosal has the advantage of ease of administration, patient compliance and are economic too. The mucosa of the buccal cavity is the most easily accessible transmuocosal site. Buccal transmucosal delivery helps to bypass first- pass metabolism by allowing direct access to the systemic circulation through the internal jugular vein. The buccal transmucosal route has been researched for a wide variety of drugs. Several methodologies have been considered so far, to design and manipulate the release properties towards the invention of buccal mucosal delivery systems. This article aims at reviewing the numerous techniques that has been designed till date for optimizing buccal transmucosal drug delivery.
References
Vogler EA. Water and the acute biological
response to surfaces. J Biomater Sci Polym
;10:1015-1045.
Jones DS, Woolfson AD, Djokic J, Coulter
WA. Development and mechanical
characterization of bioadhesive semi-solid,
polymeric systems containing tetracycline for
the treatment of periodontal diseases. Pharm
Res 1996;13:1734-1738.
Mizrahi B, Domb A. J. Mucoadhesive
polymers for delivery of drugs to the oral
cavity. Recent Pat Drug Deliv Formula
;2:108-119.
Salamat-Miller N, Chittchang M, Johnston
TP. The use of mucoadhesive polymers in
buccal drug delivery. Adv Drug Deliv Rev
;57:1666-1691.
Woodley J. Bioadhesion new possibilities for
drug administration. Clin Pharmacokinet
;40:77-84.
Harding SE .Mucoadhesive interactions.
Biochem Soc Trans 2003;31:1036-1041.
Haas J, Lehr CM. Developments in the area
of bioadhesive drug delivery systems. Expert
Opin Biol Ther 2002;2:287-298.
Edsman K, Hagerstrom H. Pharmaceutical
applications of mucoadhesion for the non-oral
routes. J Pharm Pharmacol 2005;57:3-22.
Jimenez MR, Castellanous, Zia H, Rhodes
CT. Drug Dev Ind Pharm 1993;19:143.
Bomberag LE, Buxton DK, Friden PM.
Novel periodontal drug delivery system for
treatment of periodontitis. J.Control.Rel
;71:251-259.
James C, Boylan. Drug delivery buccal route.
In: James Swarbrick, editor. Encyclopedia of
Pharmaceutical Technology: Supplement 3,
Marcel Dekker INC 2001; Vol 20:P. 800-11
Metia PK, Bandyopadhyay AK. In vitro
evaluation of novel mucoadhesive buccal
tablet of oxytocin prepared with Diospyros
peregrina fruit mucilages. Yakugaku Zasshi
;128:603-609.
Tanabe M, Watanabe M, Yanagi M,
Nishizawa S, Chigono Y, Matsuda J,
Yamaoka K, Inoue K. Controlled
film in vitro and clinical evaluations.
Yakugaku Zasshi 2008;128:1673-1679.
Malik DK, Baboota S, Ahuja A, Hasan S, Ali.
Recent advances in protein and peptide drug
delivery systems. J Curr Drug Deliv
;4:141-151.
Munasur VAP, Pillay DJ, Chetty, Govender
T. Statistical optimization of the
mucoadhesivity and characterization of
multipolymeric propranolol matrices for
buccal therapy. International Journal of
Pharmaceutics 2006;323:43-51.
Wong.TW. Chitosan and its use in design of
insulin delivery system. Recent Pat Drug
Deliv Formul 2009;3:8-25.
Ludwig A. The use of mucoadhesive
polymers in ocular drug delivery.Adv Drug
Deliv Rev 2005;57:1595-1639.
Chopra S, Mahdi S, Kaur J, Iqbal Z,
Talegaonkar S, Ahmad FJ. Advances and
potential applications of chitosan derivatives
as mucoadhesive biomaterials in modern drug
delivery. J Pharm Pharmacol 2006;58:1021-
Sudhakar Y, Knotsu K, Bandopadhyay AK.
Bio adhesive drug delivery – A promising
option for orally less efficient drugs. J
Control Rel 2006;114:15-40.
Silvia Rossi, Giuseppina Sandri , Carla M.
Caramella. Buccal drug delivery -A challenge
already won. Drug Spring 2005;2:59-65.
Di Colo G, Zambito Y, Zaino C. Polymeric
enhancers of mucosal epithelia permeability:
synthesis, transepithelial penetrationenhancing properties, mechanism of action,
safety issues. J Pharm Sci 2008;97:1652-
Senel S, Hincal AA. Drug permeation
enhancement via buccal route: possibilities
and limitations. J Control Release
;72:133-144.
Sayani AP, Chien YW. Systemic delivery of
peptides and proteins across absorptive
mucosa. Crit Rev Ther Drug Carrier Syst
;13:85-184.
Rajashree Mashru, Vijay Sutariya, Mayur
Sankalia, Jolly Sankalia. Transbuccal delivery
of lamotrigine across procine buccal mucosa
in vitro determination of routes of buccal
transport. J Pharm Pharmaceut Sci 2005;8:54-
Ceschel GC, Maffei P, Moretti MD,
Demontis LS, Peana A. International Journal
of Pharmaceutics 2000;195:45.
Miyazaki S, Nakayama A, Oda M, Takada M,
Attwood D. Chitosan and sodium alginate
based bioadhesive tablets for intraoral drug
delivery. Biol Pharm Bull 1994;17:745–747.
Ceschel GC, Maffei P, Borgia SL. Design and
evaluation of a new Mucoadhesive bilayered
tablet containing nimesulide for buccal
administration. Drug Deliv 2004;11:225–230.
Remunan-Lopez C, Portero A, Vila-Jato JL,
Alonso MJ. Design and evaluation of
chitosan/ethyl cellulose mucoadhesive
bilayered devices for Buccal drug delivery. J.
Control. Release 1998;55:143–152.
Abuja A, Khar RK, Ali J. Mucoadhesive drug
delivery systems. Drug Dev. Ind. Pharm
;23:489–517.
Bouckaert S, Schautteet H, Lefebvre RA,
Remon JP, Clooster RV. Double-layered
mucoadhesive tablets containing nystatin.
Eur. J. Clin.Pharmacol 1992;43:137.
Gupta A, Garg S, Khar RK. Interpolymer
complexation and its effect on bioadhesion
strength and dissolution characteristics of
buccal drug delivery systems. Drug Dev Ind
Pharm 1994;20:315–325.
Taylan B, Capan Y, Guven O, Kes S, Hincal
AA. Design and evaluation of sustained
release and buccal adhesive propronolol
hydrochloride tablets. J Control Release
;38:11–20.
Desai KGH, Kumar TMP. Preparation and
evaluation of a novel buccal adhesive system.
AAPS PharmSciTech 2004;5:1–9.
Goud HK, Kumar TMP. Preparation and
evaluation of a novel buccal Adhesive
systems. AAPS PharmSciTech 2004;5:35.
Labot JM, Manzo RH, Allemandi A. Double
layered mucoadhesive tablets containing
nystatin. AAPS PharmSciTech 2002;3:22.
Rajesh K, Agarwal SP, Ahuja A.
Buccoadhesive erodible carriers for local drug
delivery: design and standardization. Int J
Pharm 1996;138:68–73.
Nagai T. Adhesive topical drug delivery
system. J Control Release 1985;2:121–134.
Ceschel GC, Maffei P, Borgia SL, Ronchi C.
Design and evaluation of buccal adhesive
hydrocortisone acetate tablets. Int J Pharm
;238:161–170.
Rafiee-Tehrani M, Jazayeri G, Toliyat T,
Bayati K, Khalkhali K, Shamimi K,
Miremadi A, Dorkoosh FA. Development and
in-vitroevaluation of novel buccoadhesive
tablet formulation of prednisolone, Acta
Pharm 2002;52:123–130.
Nagai T, Konishi R. Buccal/gingival drug
delivery systems. J. Control. Release
;6:353–360.
Agarwal V, Mishra B. Design development
and biopharmaceutical a property of
buccoadhesive compacts of pentazocine.
Drug Dev Ind Pharm 1999;25:701–709.
Cassidy JP, Landzert NM, Quadros E.
Controlled buccal delivery of Buprenorphine.
J Control Release 1993;25:21–29.
Anlar S, Capan Y, Guven O, Gogus A,
Dlakara T, Hincal AA. Formulation and in
vitro and in vivo evaluation of buccoadhesive
morphine sulphate tablets. Pharm. Res
;11:231–236.
Choi HG, Kim CK. Development of
Omeprazole buccal adhesive tablets with
stability enhancement in human saliva. J
Control Release 2000;68:397–404.
Choi H, Jung J, Yong CS, Rhee C, Lee M,
Han J, Park K, Kim C. Formulation and in
vivo evaluation of Omeprazole buccal
adhesive Tablet. J Control Release
;68:405–412.
Park CR, Munday DL. Development and
evaluation of a biphasic buccal adhesive
tablet for nicotine replacement therapy. Int J
Pharm 2002;237:215–226.
Ikinci G, Senel S, Wilson CG, Şumnu M.
Development of buccal bioadhesive nicotine
tablet formulation for smoking cessation. Int J
Pharm 2004;277:173–178.
Nagai T, Machida Y. Buccal delivery systems
using hydrogels. Adv Drug Del Rev
;11:179–191.
Ponchel G, Touchard F, Wouessidjewe D,
Duchene D, Peppas NA. Bioadhesive analysis
of controlled release systems III. Bioadhesive
and release behaviour of metronidazole
containing poly (acrylic acid)- hydoxypropyl
methylcellulose systems. Int J Pharm
;38:65–70.
Alur HH, Pather SI, Mitra AK, Johnston TP.
Transmucosal sustained-delivery of
chlorpheniramine maleate in rabbits using a
novel natural mucoadhesive gum as an
excipient in buccal tablet. Int J Pharm
;188:1–10.
Mizrahi B, Golenser J, Wolnerman JS, Dombi
AJ. Adhesive tablet effective for treating
canker sores in humans. Assoc J Pharm Sci
;93:2927–2935.
Du Q, Ping QN, Liu GJ. Preparation of
Buspirone hydrochloride buccal adhesive
tablet and study on its drug release
mechanism. Yao Xue Xue Bao 2002;37:653–
Tsutsumi K, Obata Y, Nagai T, Loftsson T,
TakayamaK. Buccal absorption of ergotamine
tartrate using the bioadhesive tablet system in
Guinea-pigs. Int J Pharm 2002;238:161–170.
Dinsheet, Agarwal SP, Ahuja A. Preparation
and evaluation of buccal adhesive tablets of
Hydralazine hydrochloride. Indian J Pharm
Sci 1997;59:135–141.
Beyssac E, Aiche JM, Chezaubernarul C,
Caplin H, Douin MJ. Renoux A. Proc Int
Symp Control. Rel Biact Mater. Contr Rel Sci
;21.
Collins AE, Deasy PB. Bioadhesive lozenge
for the improved delivery of cetylpyridinium
chloride. J Pharm Sci 1990;79:116.
Cui Z, Mumper RJ. Bilayer films for mucosal
(genetic) immunization via the buccal route in
rabbits. Pharm Res 2002;19:947–953.
Perugini P, Genta I, Conti B, Modena T,
Pavanetto F. Periodontal delivery of
ipriflavone new chitosan/PLGA film delivery
system for a lipophilic drug. Int J Pharm
;18:1–9.
Senel S, Ikinci G, Kas G, Yousefi-Rad A,
Sargon MF, Hıncal AA. Chitosan films and
hydrogels of chlorhexidine gluconate for oral
mucosal Delivery. Int J Pharm 2000;193:197–
Tiwari D, Goldman D, Sause R, Madan PL.
Evaluation of Polyoxyethylene
homopolymers for buccal bioadhesive drug
delivery device formulations. AAPS
PharmSci 1999;1:1–8.
Guo JH. Investigating the surface properties
and bioadhesion of buccal Patches. J Pharm
Pharmacol 1994;46:647–650.
Danjo K, Kato H, Otsuka A, Ushimaru K.
Fundamental study on the evaluation of
strength of granular particles. Chem Pharm
Bull 1994;42:2598–2603.
Ishida M, Nambu N, Nagai T. Mucosal
dosage form of lidocaine for toothache using
hydroxypropyl cellulose and carbopol. Chem
Pharm Bull 1982;30:980–984.
Nafee NA, Ismail FA, Nabila A, Boraie LM.
Mucoadhesive buccal patches of miconazole
nitrate in vitro/in vivo performance and effect
of ageing. Int J Pharm 2003;264:1–14.
Save T, Shah UM, Ghamande AR,
Venkatachalam P. Comparative study of
buccoadhesive formulations and sublingual
capsules of nifedipine. J Pharm Pharmacol
;46:192–195.
Shojaei AH, Li X. Mechanisms of buccal
mucoadhesion of novel copolymers of acrylic
acid and polyethylene glycol
monomethylether monomethacrylate. J
Control Release 1997;47:151–161.
Hoogstraate AJ, Verhoef JC, Pijpers A,
Leengoed LAV, Verheijden JH, Junginger,
HE, Bodde. In vivo buccal delivery of the
peptide drug buserelin with
glycodeoxycholate as an absorption enhancer
in pigs. Pharm Res 1996;13:1233–1237.
Alur H, Beal JD, Pather SI, Mitra AK,
Johnston TP. J Pharm Sci 1999;88(12):1313–
Yaziksiz-Iscan Y ,Capan Y, Senel S, Sahin
MF, Kes S, Duchene, AA, Hincal, STP
Pharma Pharm Sci 1998;8:357–363.
Ito Y, Hu Z, Yoshikawa M, Murakami M,
Takada K. Proc Int Symp .Control Release
Bioact Mater 1999;26:6303–6304.
Mcelnay JC, Furaih TA, Hughes CH, Scott
MG, Elborn JS, Nicholls DP. Eur. J. Clin.
Pharmacol 1998;54:609–614.
Gutniak MK, Larsson H, Heiber SJ,
Juneskans OT, Holst JJ, Ahren B, Diabetes
Care 1996;19:843–848.
Chien Y, Nakane S, Lee Y, Kakumoto M,
Yukimatsu K. Proc. 1st World Meeting
APGI/APV, Budapest; 1995;813–814.
Towey MG, Maury C. J Interferon Cytokine
Res 1999;19(2):145–155.
Zhang J, Nui S, Ebert C, Stanley TH. Int J
Pharm 1994;101:15–22.
Nakane S, Kakumoto M, Yukimatsu K, Chien
YW. Pharm Dev Technol 1996;1:251–259.
Merkle HP, Wolany GJM. J Control Release
;21:155–164.
Li C, Padmanabh PB, Johnston TP. Pharm
Dev Technol 1997;2(3):265–274.
Anders R, Merkle HP, Schurr W, Ziegler R. J
Pharm Sci 1983;72:1481–1483.
Bayley D, Temple C, Clay V, Steward A,
Lowther NJ. Pharm. Pharmacol 1995;47:721–
